About the Authors

Nikola Sprigg

Affiliation Stroke Trials Unit, Institute of Neuroscience, University of Nottingham, Nottinghamshire, United Kingdom

Laura J. Gray

Affiliation Stroke Trials Unit, Institute of Neuroscience, University of Nottingham, Nottinghamshire, United Kingdom

Tim England

Affiliation Stroke Trials Unit, Institute of Neuroscience, University of Nottingham, Nottinghamshire, United Kingdom

Mark R. Willmot

Affiliation Stroke Trials Unit, Institute of Neuroscience, University of Nottingham, Nottinghamshire, United Kingdom

Lian Zhao

Affiliation Stroke Trials Unit, Institute of Neuroscience, University of Nottingham, Nottinghamshire, United Kingdom

Gillian M. Sare

Affiliation Stroke Trials Unit, Institute of Neuroscience, University of Nottingham, Nottinghamshire, United Kingdom

Philip M. W. Bath

philip.bath@nottingham.ac.uk

Affiliation Stroke Trials Unit, Institute of Neuroscience, University of Nottingham, Nottinghamshire, United Kingdom

Competing Interests

Philip Bath has consulted for Boehringer Ingelheim and has spoken at symposia related to dipyridamole.

Author Contributions

Conceived and designed the experiments: PMWB. Performed the experiments: NS MRW LZ. Analyzed the data: LJG. Wrote the paper: NS TE PMWB. Performed blinded adjudication of adverse events: TE. Prepared adverse event summaries: GS.